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ABSTRACT:  
 
This protocol describes a robust and reproducible method for the preparation of 
highly viable adult ventricular myocardial slices from small and large mammalian 
hearts. Adult ventricular myocardial slices are 100-400μm-thick slices of living 
myocardium that retain the native multicellularity, architecture and physiology of the 
heart. This protocol provides a list of the equipment and reagents required alongside 
a detailed description of methodology for heart explantation, tissue preparation, 
slicing with a vibratome and handling of myocardial slices. Supplementary videos are 
included to visually demonstrate these steps.  A number of critical steps are 
addressed that must be followed in order to prepare highly viable myocardial slices. 
These include: identification of myocardial fiber direction and fiber alignment within 
tissue block, careful temperature control, use of an excitation-contraction uncoupler 
and optimal vibratome settings and correctly handling myocardial slices. Many 
aspects of cardiac structure and function can be studied using myocardial slices in 
vitro. Typical results obtained from rat (small mammal) & human heart failure (large 
mammal) samples are shown, demonstrating myocardial slice viability, maximum 
contractility, Ca2+ handling & structure. This protocol can be completed in ~4 hours. 
 
INTRODUCTION:  
 
Myocardial slices are 100-400μm-thick slices of living adult ventricular myocardium, 
prepared using a high precision vibratome(1–25) (Fig. 1). They retain the 
multicellularity, complex architecture and physiology of adult cardiac tissue and their 
thinness allows the diffusion of oxygen and other metabolic substrates to their 
innermost cells, maintaining viability in the absence of coronary perfusion in vitro(2). 
Slices have been produced from a number of small and large mammals, including 
mice(3,15,16,21), rats(4,8–14,17–20,22–24), guinea pigs(5,13,14), rabbits(5), 
dogs(3,6,25), pigs and human tissue biopsies(2,3,6,7,25). Multiple slices can be 
produced from each heart or biopsy, reducing the number of animals required for 
studies. 
 
[Insert Fig. 1 here] 
 
Development & applications 
 
In recent years, myocardial slices have been increasingly utilised, however, they 
were first used as far back as the 1970s. Early studies investigated a number of 
aspects of cardiac function including biochemistry (8), metabolism(9,18–21), 
electrophysiology(10,11) and pharmacological cardiotoxicity(4). These studies 
demonstrated that myocardial slices had wide-ranging applications, but it was not 
until the early 2000s that they became more widely recognized. During this period, 
myocardial slices were found to have more representative electrophysiological 
properties than other cardiac models(12) and other functional parameters, including 
myocardial slice contractility(15), were measured for the first time. Importantly, 
techniques to culture slices for up to one week were developed(15) and more recent 
use of an air-liquid interface has demonstrated that slices can be maintained for up 
to one month in vitro(2). 
 
As myocardial slices provide a clinically relevant and representative human model 
system in vitro they are particularly useful for translational studies(7). A substantial 
amount of work has demonstrated that myocardial slices can be used for 
pharmacological testing and in vitro drug safety screening(6,7,13,14,22). They have 
also been used to study the integrative capacity of a number of cell types as part of 
the development of cell-replacement strategies(16,26,27). More recently, slices have 
been used to test the clinical applicability of conductive polymer patches (17).  
 
Despite the number of studies published, the protocols used have varied greatly. 
There are a number of critical steps that need to be carefully controlled to produce 
myocardial slices with high viability and this optimized protocol has significantly 
improved their contractility (Supplementary Fig. 1) alongside other structural and 
functional parameters. A critical step, that is often overlooked, is the identification of 
myocardial fiber direction and fiber alignment within the tissue block. In a large 
number of papers published, hearts are sliced in the short-axis. As myocardial fibers 
run parallel to the epicardium, this results in a large numbers being transected and 
substantial tissue damage. Other critical steps include: carefully maintaining the 
correct temperature, the use of an excitation-contraction uncoupler and optimal 
vibratome settings and correctly handling the myocardial slices. These factors and 
the techniques used to control them are discussed in depth in this protocol. 
 
Comparison with other methods 
 
Cardiovascular research has been conducted using a variety of model systems.  
 
Isolated adult cardiomyocytes.  Isolated adult cardiomyocytes have been used 
widely. During isolation, cardiomyocytes lose connections with other cardiac cells 
and the ECM, both of which are known to modulate myocardial function(28,29), and 
the outcomes of different isolation protocols are known to vary noticeably(30). 
Isolated cardiomyocytes also undergo significant remodeling within hours(31,32), 
with significant implications for the relevance of chronic studies(32).  
 
Whole hearts.  Whole heart studies avoid the issues associated with cell isolation. 
However, it is extremely difficult to use isolated whole hearts for more than a few 
hours and investigations therefore require large numbers of animals. Their 
complexity also makes it is difficult to study events at the cellular level and these 
studies require specific and expensive set ups. Other intermediate preparations 
exist, including cardiac wedges and papillary muscles, but these often become 
ischaemic ex vivo(33), particularly when prepared from large mammals.  
 
Stem cell derived cardiomyocytes.  In recent years, human pluripotent stem cell-
derived cardiomyocytes (PSC-CMs) have been utilised. While these cells have the 
advantage of recreating pathological phenotypes in vitro(34), they also have a 
relatively naïve phenotype(35), with many aspects including morphology, 
metabolism(36), electrophysiology and Ca2+ handling(37) regarded as particularly 
immature.  
 
Myocardial slices.  Myocardial slices bridge the gap between isolated 
cardiomyocytes and whole heart studies. The multicellular composition and non-
cellular architecture of the myocardium are almost fully maintained during slicing, 
resulting in a model with the correct cell ratios and cell-cell / cell-ECM interactions. 
This allows all cardiac cell populations, including fibroblasts and endothelial cells, to 
be studied alongside one another, which is required to improve our understanding of 
cardiac physiology and pathology(38). Additionally, chronic culture is facilitated by 
the ability of oxygen and metabolic substrates to diffuse to all of the cells within the 
preparation, which is not possible or very difficult to achieve with other cardiac 
multicellular preparations(2).  
 
Experimental design 
 
When designing experiments using myocardial slices, the number of slices that can 
be produced must be considered. Smaller mammals, including mice and rats, can 
yield 3-6 slices per heart, while large mammals, including canine or human biopsies, 
can yield 20-30 slices per tissue block and several tissue blocks can be prepared 
from the left ventricle. As multiple slices can be produced from each animal, many 
experiments can be conducted, ultimately reducing the number of animals used in 
studies. The age and phenotype of the animal can also contribute to the thickness of 
the ventricular wall and should be considered. Another important consideration is the 
region of the ventricular wall from which the slice has been derived. The 
endocardium, midmyocardium and epicardium have differing electrophysiological 
and contractile properties(39) and also display varied responses to pharmacological 
stimuli(40). This can be overcome by using slices from specific regions or by 
randomizing slices and increasing the number of repeats. The timings of 
experiments should also be considered carefully. Slices should be used as swiftly as 
possible, but can be kept in ice-cold, oxygenated Tyrode’s solution for up to 4 hours 
prior to being used. Exceeding this time period may result in degradation of the 
myocardial slices.  
 
Limitations & expertise required 
 
While myocardial slices have a number of benefits over other cardiac preparations, 
they also have their limitations. The biggest determinant of myocardial slice quality is 
the method by which the cardiac tissue block is dissected & prepared. Due to the 
manual nature of this process there is a relatively steep learning curve and a number 
of weeks and animals (10-15 hearts) should be dedicated to practicing before high 
quality tissue blocks can be consistently prepared. The quality of the tissue block 
preparation directly correlates to the quality of data that can be collected (See 
“Anticipated Results – Viability”). Access to fresh cardiac tissue / animal facilities and 
the expense of equipment (See “Equipment”) may also be prohibitive for some 
laboratories.  
 
Summary 
 
In summary, myocardial slices provide significant advantages over other commonly 
utilised cardiac preparations and can be produced from a large variety of species. 
The protocols used to date vary greatly and there are a number of critical steps that 
need to be addressed in order to produce myocardial slices with high viability and 
preserved structure and function. This protocol describes a robust and reproducible 
technique for producing myocardial slices and aims to standardize the methodology 
by which they are produced, reducing the variability in the quality of myocardial 
slices produced in different laboratories.   
 
MATERIALS: 
 
Reagents 
• Fresh mammalian cardiac tissue. Rodent, human heart failure, porcine and 
canine cardiac tissues were used to produce myocardial slices. All animal 
experiments must comply with Institutional and National regulations.  Our use 
of living cardiac tissue was approved by Imperial College London. The 
procedures we describe here were performed under license by the UK Home 
Office, in accordance with the United Kingdom Animals (Scientific 
Procedures) Act 1986. Animals were killed following guidelines established by 
the European Directive on the protection of animals used for scientific 
purposes (2010/63/EU). Human samples were provided by the NIHR 
Cardiovascular Biomedical Research Unit at the Royal Brompton and 
Harefield NHS Foundation Trust and Imperial College London. The inferior 
1/3rd of explanted hearts were obtained from end-stage heart failure patients 
undergoing cardiac transplantation. The study performed conformed to the 
principles outlined in the Declaration of Helsinki and the investigation was 
approved by a UK institutional ethics committee (Ref: 09/H0504/104+5 CBRU 
Biobank). !CAUTION Informed consent was obtained from each patient 
involved in this study. Porcine hearts were obtained from the Translational 
Biomedical Research Centre, University of Bristol. Procedures were approved 
by the University of Bristol. 18 month old healthy Beagle dog hearts were 
donated by GlaxoSmithKline, after the animals were necessarily sacrificed at 
the end of pharmacology/toxicology studies. Only control animals were used.  
• 2,3-Butandione Monoxime (Acros Organics, cat. no. AC150375000) 
• Agarose (Sigma, cat. no. A9539) 
• Bovine Serum Albumin (Sigma, A7030) 
• Calcium Chloride (1M Solution) (VWR, cat. no. E506-500ML) 
• D-Glucose Anhydrous (Fisher Chemical, cat. no. D16-1) 
• Ethanol (VWR, cat. no. 64-17-5) 
• Fetal Bovine Serum (Gibco, cat. no. 10270) 
• Formaldehyde Solution (Sigma, cat. no. F8775) 
• Heparin Sodium 1000IU/ml (Fannin, PL 20417/0109)  
• HEPES (Sigma, cat. no. H3375) 
• Horse Serum (Heat Inactivated) (Gibco, cat. no. 26050088) 
• ITS Liquid Media Supplement (100x) (Sigma, cat. no. I3146) 
• Magnesium Chloride Hexahydrate (VWR, cat. no. 97061-356)  
• Magnesium Sulphate (Sigma, cat. no. M2643)  
• Medium-199 (Sigma, cat. no. M5430) 
• Penicillin-Streptomycin (Sigma, cat. no. P4333) 
• Potassium Chloride (Sigma, cat. no. P9541) 
• Phosphate Buffered Saline (Oxoid, cat. no. BR0014G) 
• Sodium Chloride (VWR, cat. no. 470302-522) 
• Sodium Bicarbonate (Sigma, cat. no. S5761) 
• Sodium Hydroxide (Fisher Chemical, cat. no. S/4880/60)   
• Sodium Phosphate Monobasic Monohydrate (Sigma, cat. no. S3522)  
• Triton X-100 (Sigma, cat. no. X100) 
 
Equipment 
• 100% Medical Grade Oxygen Gas 
• 150 x 15mm Petri Dish (Falcon, cat. no. 351058) 
• 28mm Syringe Filter (0.2 Micron) (SFCA+PF Membrane) (Corning, cat. no. 
431219); other 0.2 micron filters are appropriate 
• 40μm Cell Strainer (Corning, cat. no. 352340) 
• 6 Well Plate (Customized with holes in base of each well – See “Fig. 2A”) 
(Corning, cat. no. CLS3506) 
• Ceramic Vibratome Blades (Campden Instruments, cat. no. 7550-1-C); 
stainless steel blades can be used for single use as they wear quickly 
• Disposable Sterile Scalpel - Surgical Steel Blades (Swann-Morton, cat. no. 
05XX) 
• Electronic Balance  
• Flat Spatula 
• Gauze 
• Glass Beaker (1L / 0.25L) (Duran, cat. no. Z231894  / Z231843); other glass 
beakers are appropriate 
• Glass Petri Dish 100x20mm Soda-Lime (VWR, cat. no. CLS70165101); other 
glass petri dishes are appropriate 
• Graefe Forceps (0.8x0.7mm) (Fine Science Tools, cat. no. 11050-10); other 
small forceps are appropriate 
• Histoacryl Surgical Glue (Braun, cat. no. 1050052) 
• Incubator; 37 degrees & 5% CO2 required 
• Laboratory Bottles (1L / 0.5L) - High-Density Polyethylene, Wide Mouth 
(Nalgene, cat. no. 10547341 / 10633141); other laboratory bottles are 
appropriate 
• Laminar flow cabinet with UV light 
• Large glass dish ± lid (See “FIGURE 3C”) 
• Magnetic Stirring Bars 
• MS-H-S Circular-top Analog Hotplate Stirrer (Scilogex, cat. no. 
811121029999); other hotplate stirrers are appropriate 
• Noyes Spring Scissors (14mm Blade - 15012-12) (Fine Science Tools, cat. 
no. 15012-12); other small dissecting scissors are appropriate 
• Parafilm "M" Laboratory Film (Bemis, cat. no. PM992) 
• Pasteur Pipette (Sterile) (VWR, cat. no. 612-1685) 
• pH Meter  
• Polythene Bag 
• Rapid-Flow Sterile Disposable Filter Unit (PES Membrane - 0.2μm) (Nalgene, 
cat. no. 167-0045); other 0.2μm filters are appropriate 
• Razor Blade 
• Scissors Iris Straight 11.5cm (4.5") (Rocialle, cat. no. RSPU100-093); other 
surgical scissors are appropriate 
• Self-Seal Sterilization Pouch (Westfield Medical, cat. no. WPSS135255)  
• Stainless Steel Plain Washer (RS, cat. no. 189-636) 
• Sterilin Polystyrene Containers (Thermo Scientific, cat. no.11319143) 
• Transwell® Polyester Membrane Cell Culture Inserts (Corning, cat. no. 
CLS3450)  
• Vibrating Microtome 7000smz-2 (Campden Instruments, cat. no. 7000smz-2) 
Note: Alternative vibratomes can be used. !CAUTION Alternative vibratomes 
must be able to check and calibrate Z-axis error, be capable of cooling slicing 
solution <8oC (ideally solution should be kept at 4oC) and be capable of 
advancing at slow speeds (0.03mm/s). 
• Vibrating Microtome Bath (Campden Instruments, cat. no. 7000-3-1A) 
 
 
Reagent Setup 
 
Preparation of 1L slicing solution (Tyrode’s Solution + 30mM BDM)  
 
Cardiac tissue is sliced in Tyrode’s solution with the addition of an excitation-
contraction uncoupler (2,3-Butanedione Monoxime). Add the following to 1L distilled 
water while mixing using a magnetic stirrer: 3.00g 2,3-Butanedione Monoxime 
(30mM), 8.18g Sodium Chloride (140mM), 0.45g Potassium Chloride (6mM), 1.86g 
Glucose (10mM), 2.38g HEPES (10mM), 1ml 1M Magnesium Chloride solution 
(1mM) & 1.8ml 1M Calcium Chloride solution (1.8mM; see also Table 1 for details of 
the components required). Wait for the reagents to dissolve and then measure the 
pH. Add drops of 2M Sodium Hydroxide solution until the solution is pH 7.40. Filter 
the solution with a 0.2 micron pore filter and transfer to the previously sterilized 1L 
container. Cool the solution to 4oC. !CAUTION For large mammalian hearts >1L may 
be required. CRITICAL Must be made up fresh on the day of the experiment. 
CRITICAL Prepare slicing solution first. This needs to be cooled to ~4oC prior to 
starting procedure. CRITICAL If myocardial slices are to be cultured, all solutions 
must be filter-sterilized prior to starting procedure. 
 
Table 1  
 
Table 1: Preparation of 1L slicing solution (Tyrode's solution + 30mM BDM) 
 
Add the following to 1L distilled water: 
Solid reagents: 
 Mass (g) Final concentration (mM) 
2,3-Butanedione Monoxime 3.00 30.00 
Glucose 1.86 1.00 
HEPES 2.38 10.00 
Potassium Chloride 0.45 6.00 
Sodium Chloride 8.18 140.00 
Solutions: 
 Volume (ml) Final concentration (mM) 
1M Magnesium Chloride 1.00 1.00 
1M Calcium Chloride 1.80 1.80 
 
Preparation of hot & cold heparinized slicing solution 
 
Take 2x 60ml containers and fill with slicing solution. Add 100IU Heparin Sodium 
(1000IU/ml) to each container (100μl in 50ml slicing solution). Cool one container to 
4oC and warm the other to 37oC. CRITICAL Must be made up fresh on the day of the 
experiment. 
 
Preparation of 1L cardioplegia solution 
 
This is only required for the cardioplegic arrest of large mammalian hearts in situ or 
the transportation of cardiac tissue specimens. Alternatively, pre-made clinical grade 
cardioplegia can be purchased and used. 
 
To make up, add the following to 1L distilled water while mixing using a magnetic 
stirrer: 0.99g Glucose (5.50mM), 0.13g Magnesium Sulphate (0.50mM), 1.79g 
Potassium Chloride (24.00mM), 1.68g Sodium Bicarbonate (20.00mM), 6.37g 
Sodium Chloride (109.00mM), 0.12g Sodium Phosphate Monobasic Monohydrate 
(0.90mM) & 1.8ml 1M Calcium Chloride solution (1.8mM; see also Table 2 for details 
of the components required). Wait for the reagents to dissolve and then measure the 
pH. Add drops of 2M Sodium Hydroxide solution until the solution is pH 7.40. Filter 
the solution with a 0.2 micron pore filter and transfer to the previously sterilized 1L 
container. Cool the solution to 4oC. CRITICAL Must be made up fresh on the day of 
the experiment. 
 
Table 2: Preparation of 1L cardioplegia solution 
 
Add the following to 1L distilled water 
Solid reagents: 
 Mass (g) Final concentration (mM) 
Glucose 0.99 5.50 
Magnesium Sulphate 0.13 0.50 
Potassium Chloride 1.79 24.00 
Sodium Bicarbonate 1.68 20.00 
Sodium Chloride 6.37 109.00 
Sodium Phosphate Monobasic 
Monohydrate 
0.12 0.90 
Solutions: 
 Volume (ml) Final concentration (mM) 
1M Calcium Chloride 1.80 1.80 
 
 
Preparation of 4% Agarose 
Dissolve 4% agarose (4g in 100ml) in distilled water. Heat and stir until the agarose 
has melted (~80oC). Pour the hot agarose solution into large glass petri dishes to a 
height of 2-3mm. Leave to cool on a flat surface. Once the agarose has cooled and 
solidified, cover with Parafilm and keep at 4oC for up to 1 month. 
 
CRITICAL It is crucial that the agarose is as flat as possible.  
 
Equipment Setup 
 
Sterilization of tools & equipment  
 
This is only required for chronic studies that require myocardial slice culture. 
 
To preserve sterility and prevent infections during culture, it is important to keep the 
vibratome and tools as clean as possible. Place all the tools, including small 
tweezers, micro dissecting spring scissors, surgical scissors and the vibratome 
specimen holder in self-seal sterilization pouch and autoclave. Transfer the non-
autoclavable pieces of equipment (1L container + lid, vibratome bath, glass dish ± lid 
& customized 6 well plate) to a sterile laminar flow hood, spray with 70% ethanol and 
expose to UV light for one hour. CRITICAL Sterilization takes 1 hour. Sterilize 
equipment before setting up other pieces of equipment. 
 
Vibratome calibration  
 
Ensure the vibratome is clean by spraying with 70% ethanol and wiping dry. To work 
in complete sterility, place the vibratome in a sterile laminar flow hood. Mount a new 
ceramic blade. It is crucial to adjust the blade alignment until the Z-axis error is 
<1.0μm. If it is not possible to achieve a Z-axis error <1.0μm, remove the blade and 
wipe clean with ethanol before remounting. If achieving a Z-axis error <1.0μm is still 
not possible, the blade may be damaged and will need to be replaced. Once 
satisfied with blade alignment, mount the blade protector to avoid injuries.  
 
TROUBLESHOOTING 
 
Mounting of agarose on specimen holder 
 
Remove the 4% agarose from the fridge. Cut a 2.5cm2 piece of agarose. Place a 
large drop of histoacryl glue in the center of the base of the specimen holder. Using 
tweezers carefully pick up the square of agarose and place on the base of the 
specimen holder. Wait 30 seconds for the agarose to attach. Cut another 2.5cm2 of 
agarose. Apply histoacryl glue to the back of the specimen holder and place the 
second square here. Wait 30 seconds for it to attach. The agarose-covered 
specimen holder should be as pictured in Fig. 2B. Place the specimen holder in a 
polythene bag and keep at 4oC. Specimen holder should be prepared on day of 
experiment. CRITICAL Make sure the agarose is completely flat as the tissue will be 
mounted on top. Uneven agarose can result in poor alignment of myocardial fibers 
and subsequent tissue damage. 
 
Preparation of tissue dissection area 
 
The tissue dissection area needs to be prepared in advance to minimize delays. 
Choose an area of the bench or sterile laminar flow hood close to the vibratome. The 
following will be required for dissection: 15cm Petri Dish, sterile surgical scalpel/razor 
blade, small tweezers, micro-scissors, Histoacryl surgical glue, surgical scissors 
(large mammal only) and specimen holder with agarose. Organise the dissection 
area as pictured in Fig. 2D.  
 
 
Preparation of vibratome & holding bath  
 
Mount the vibratome bath on the vibratome. Connect the waste tubing to a 500ml 
container. Fill the outer part of the vibratome bath with ice or set the bath cooling 
system to 4oC. Remove the slicing solution from the fridge and pour into the inner 
part of the vibratome bath. Bubble the solution with filtered 100% oxygen, making 
sure the tip of the tubing has been sterilized. The myocardial slice holding bath, 
which can hold slices prior to experiments, should also be prepared. Place the glass 
dish on ice. The 6 well dish with holes (Fig. 2A) should be placed inside and a cell 
strainers inserted into each well. Fill the dish with enough cold slicing solution to 
cover all the wells. Oxygenate the solution and cover the container with a lid. The set 
up should be as pictured in Fig. 2C/E. 
 
[Insert Fig. 2 here] 
 
PROCEDURE 
 
Excision of mammalian heart 
 
!CAUTION Experiments involving live animals must conform to relevant Institutional 
and National guidelines. 
 
1 Follow option A if using a small mammalian heart (for example, rodents) or options 
B, C or D if using a large mammalian heart (for example human, pig and dog, 
respectively). 
 
A) Excision of small mammalian heart (Rodents) 
Time required: 5 minutes 
 
CRITICAL The following procedure minimizes the pain, suffering and distress of 
rodents, while allowing the rapid excision of the rodent heart following sacrifice. This 
is crucial to obtain highly viable slices.  
 
i. Sedate the rodent with isofluorane (4% isoflurane and 4L/min oxygen). 
 
ii. Sacrifice the rodent following Institutional & National guidelines. Our 
laboratory performs cervical dislocation and death is confirmed via dissection 
of the carotid arteries. 
 
iii. Place the rodent in the supine position.  
 
iv. Locate the sternum. Hold the overlying skin with tweezers and make a small 
incision distally.  
 
v. Once the sternum is exposed, hold with tweezers. Make an incision along the 
entirety of the costal margin using scissors.  
 
vi. Once the diaphragm has been exposed, make another incision along costal 
junction to remove the diaphragm and allow access to the mediastinum.  
 
vii. Hold the lung parenchyma with your tweezers (pulling the heart and lungs 
away from the posterior wall of the thorax) and gently move your scissors 
behind the heart and lungs. Cut through the aorta and venae cavae.  
 
viii. Remove the heart and lungs from the animal by pulling the lungs. Never 
directly hold the heart with the tweezers. 
 
CRITICAL The excision of a small mammalian heart should take no longer than 30 
seconds following the sacrifice of the animal. The heart should still be vigorously 
beating following excision. 
 
TROUBLESHOOTING. 
 
ix. Rapidly transfer the heart and lungs to your warm (37oC) heparinized slicing 
solution.  
 
x. With two fingers, gently and repeatedly compress the heart for 5-10 seconds 
to eject remaining blood from the ventricles.  
 
xi. Transfer the heart and lungs to the cold (4oC) heparinized solution and gently 
compress the heart to wash the remaining blood for 5 seconds. Keep the cold 
solution on ice and quickly transfer to the dissection area. 
 
B) Excision of large mammalian heart (Human)   
Time required: Excision = 5 mins, Transport to laboratory = 1-4 Hours 
 
i. Perfuse the heart with cardioplegia prior to explantation.  
 
ii. Following explantation and dissection of the failing heart, place the specimen 
in a 1L container with freshly made, cold (4oC) cardioplegia solution.  
 
iii. Place the container on ice and transfer to the laboratory. 
 
PAUSEPOINT Heart remains viable for further studies if kept on ice for up to 4 
hours. 
 
C) Excision of large mammalian heart (Porcine)  
 
i. Carry out procedure in a controlled manner in theatre, under general 
anesthesia, with ongoing full monitoring and with antibiotic cover.  
 
ii. Perform sternotomy and isolate the aorta and venae cavae.  
 
iii. Administer heparin (300IU/Kg) and allow to circulate for 2 minutes.  
 
iv. Clamp the aorta and venae cavae.  
 
v. Deliver 2L cold cardioplegia into the aortic route at a delivery pressure of 
300mmHg. Open the inferior vena cava at the junction of the right atrium to 
vent excess cardioplegia from the coronary sinus.  
 
vi. Cool the ventricular surface with cold saline / ice.  
 
vii. Carefully remove the heart by transecting the venae cavae and pulmonary 
veins.  
 
viii. Place the whole heart or biopsies in sterile containers with cold cardioplegia 
solution and put on ice.  
 
PAUSEPOINT Heart remains viable for further studies if kept on ice for up to 4 
hours.  
 
D) Excision of large mammalian heart (Canine) 
 
i. Kill dog with an overdose of pentobarbital sodium (Dolethal 200mg/ml 
solution for injection). 
 
ii. Confirm death. 
 
iii. Remove the rib cage to expose the thoracic cavity. Remove the heart 
immediately and place into a 1L container with freshly made, cold (4oC) 
cardioplegia solution.  
 
iv. Place the container on ice and transport to laboratory. 
 
PAUSEPOINT Heart remains viable for further studies if kept on ice for up to 4 
hours. 
 
 
Preparation of left ventricular tissue block 
 
2 Follow option A and Supplementary Videos 1-3 if using a small mammalian heart 
or option B if using a large mammalian heart. 
Time required: 5-10 minutes 
 
A) Preparation of small mammalian (Rat) left ventricular tissue block 
 
CRITICAL See Supplementary Video 1 to visualize steps 2A i-vii 
 
i. Carefully transfer the heart and lungs to the large petri dish at the tissue 
dissection area.  
 
ii. Fill the petri dish with enough 4oC slicing solution to cover at least half the 
heart and keep it cold.  
 
iii. Using a scalpel/razor blade, dissect off the lungs and other tissues to leave an 
intact heart (Fig. 3A).  
 
iv. Visualize the atria and make an incision slightly inferiorly (through the base of 
the heart) (Fig. 3B). 
  
v. From the superior position, visualize the left and right ventricular walls and the 
septum. Locate the right ventricle, which is cresentic in shape and has a 
thinner wall. With small tweezers, hold the right ventricle by its free wall (Fig. 
3C).  
 
vi. With micro-scissors in your other hand, make an incision along the right 
ventricular-septal junction towards the apex (Fig. 3D).  
 
vii. Continue to hold the right ventricle by its free wall (Fig. 3E) and cut along the 
other ventricular-septal junction to remove it (Fig. 3F). Some papillary muscles 
may also have to be cut to remove the right ventricle. 
 
CRITICAL See Supplementary Video 2 to visualize steps 2A viii – x 
 
viii. You should now have the left ventricle and septum. Locate the septum and 
make an incision down towards the apex using micro-scissors (Fig. 3G).  
 
ix. Open the left ventricle and allow it to flatten (Fig. 3H).  
 
x. If further flattening is required, make small incisions along the superior and 
inferior borders of the tissue block.  If necessary, also cut the papillary 
muscles (Fig. 3I). 
 
CRITICAL See Supplementary Video 3 to visualize step 2A xi 
 
xi. Turn the block over and use a scalpel/razor blade to remove remaining septal 
tissue from the edges of the tissue block (Fig. 3J). You should now have a 
relatively flat block of left ventricular tissue (Fig. 3K/L). 
 
CRITICAL It is critical to make the tissue as flat as possible. Use micro-scissors to 
cut large papillary muscles from the endocardial surface and remove any fibrous 
tissue or sub-valvular tissue from the basal part of the ventricle. It may also be 
necessary to make very small incisions along the borders of the tissue block to make 
it truly flat. During tissue handling it is important to keep the tissue cold to prevent the 
myocardium from contracting. 
 
TROUBLESHOOTING  
 
[Insert Fig. 3 here] 
 
B) Preparation of large mammalian (Human) left ventricular tissue block 
 
i. Transfer the heart from the container of cold cardioplegia solution to the tissue 
dissection area.  
 
ii. Remove the heart from the container and place in the large petri dish.  
 
iii. Using the scalpel/razor blade make an incision inferior to the atria and 
atrioventricular valves to leave the left and right ventricles and the septum.  
 
iv. Identify the left ventricle and locate the area of the left ventricular free wall 
with the least epicardial curvature.  
 
v. Dissect out a 1.5cm2 tissue block from this area by making incisions through 
the full thickness of the ventricular wall with a scalpel/razor blade. 
 
TROUBLESHOOTING  
 
CRITICAL Human specimens may contain regions of pathology (E.g. infarct 
scarring). Unless specifically required for experiments, these areas should be 
avoided to produce highly viable myocardial slices. 
 
Mounting tissue block  
 
CRITICAL See Supplementary Video 4 to visualize steps 3-8 
 
CRITICAL Tissue blocks are attached to the agarose-coated specimen holder 
epicardial surface down. The epicardium is significantly flatter than the endocardium 
and this helps align the myocardial fibers in the same plane within the tissue. This is 
crucial to obtain myocardial slice with high viability. 
 
3 Lightly blot the epicardial surface of the tissue block with tissue paper to remove 
excess solution from its surface.  
 
4 Apply a drop of Histoacryl glue to the agarose attached to the base of the 
specimen holder. Spread to ensure a thin and even coating of glue over the entire 
surface. 
 
5 Using small tweezers, hold and pick up the tissue block by one of its lateral edges.  
 
6 Move the left ventricle so that it is positioned directly over the specimen holder. 
Slowly lower the ventricle until the free edge of the ventricle makes contact with the 
agarose.  
 
!CAUTION Tissue will attach to the surface immediately upon contact. It is not 
possible to remove tissue once stuck. 
 
7 Smoothly roll the rest of the ventricle onto the agarose until the entire epicardial 
surface is in contact.  
 
8 Using a flat spatula, apply gentle pressure to the endocardial surface to ensure the 
tissue attaches.  
 
!CAUTION The sample should not be placed too close to the back of the specimen 
holder as this can cause slices to become trapped during slicing.  
 
9 Rapidly transfer the specimen holder to inner part of the vibratome bath. 
 
TROUBLESHOOTING  
 
Slicing  
Time required: 0.5-1.5 Hours 
 
CRITICAL See Supplementary Video 5 to visualize steps 10-14 
 
10 Once the tissue block is in position, move the blade to the correct starting 
position. Move the blade forward until it reaches the anterior border of the tissue 
block. Adjust the height of the blade to the superior border of the tissue block. The 
following settings have been optimized to maintain tissue viability while slicing. The 
blade should be set to vibrate at a frequency of 80Hz and an amplitude 2.00mm. The 
section thickness should be 300μm (although slices of thickness 100-400μm can be 
produced). While slicing, advance the blade at 0.03mm/s. Ensure Z-axis error 
<1.0μm. 
 
11 Start slicing. The blade should advance slowly and make contact with the tissue. 
 
12 Once the blade reaches the posterior border of the tissue block, stop the blade 
advancing.   
 
13 Return the blade to the starting position. Once the blade has returned to this 
position, it will automatically lower by 300μm (or the selected slice thickness).  
 
14 Start slicing. Repeat steps 11-13 until you have sliced through the full thickness of 
the ventricle.  
 
TROUBLESHOOTING  
 
Handling & storage of myocardial slices 
Time required: 1 minute 
 
CRITICAL See Supplementary Video 6 to visualize steps 15-16 
 
 
15 Once the blade has completely cut through the tissue block, a slice will detach 
from the superior surface of the tissue block. It takes 5-10 minutes to cut a slice 
(depending on tissue block dimensions) due to the slow speed at which the blade 
advances. Use a Pasteur pipette to transfer a slice to the holding bath. Move the 
pipette tip under the slice and gently lift. The slice should drape over the pipette tip. 
 
TROUBLESHOOTING  
 
!CAUTION It is important not to suck the slice inside the Pasteur pipette as this 
creates tissue damage. 
 
16 Submerge the pipette into one of the cell strainers in the holding bath to release 
the slice. Make sure the slice is flat on the cell strainer gauze. Place a circular gauze 
over the top of the slice and hold down using a washer.  
 
PAUSEPOINT Slices can be kept in the holding bath for up to 4 hours. Slices must 
be used for acute experiments or put in culture within this time period. 
 
17 Repeat further slicing.   
 
18 Ceramic blades can be used to produce myocardial slices from several animals. 
To avoid damage to the blade, we do not recommend removing it between 
experiments. Thoroughly clean the blade with 70% ethanol after each experiment. If 
multiple tissue blocks are sliced in a single day, clean the blade between each and 
recheck the z-axis error.    
 
Additional Steps: 
Culturing, fixing & staining of myocardial slices 
 
19 Follow step A for culturing or step B for fixing and staining. 
 
A) Culturing – Air-liquid interface method 
Time required: 10-15 minutes for 6 slices 
 
CRITICAL See Supplementary Video 7 to visualize steps 19 A i-viii 
 
!CAUTION The following steps must be carried out in a sterile manner in a laminar 
flow hood. Spray all items with 70% ethanol before placing them in flow hood and 
observe standard cell culture practices.  
 
i. Transfer a myocardial slice from the holding bath to a sterile petri dish 
using a Pasteur pipette. Gently pipette some cold Tyrode’s solution 
onto the slice surface to keep it cool and prevent it from drying out. 
Quickly transfer to flow hood. CRITICAL Handle myocardial slices as 
described in “Handling & storage of myocardial slices”. 
 
ii. Wash the slice with PBS + 3% Penicillin-Streptomycin at room 
temperature. 
 
iii. Myocardial slices can be cultured on an air-liquid interface using 
Transwell® membrane cell culture inserts. Use a Pasteur pipette to 
transfer the slice onto the surface of the Transwell® membrane and 
pipette some cold Tyrode’s solution into the insert. 
 
iv. Gently remove the solution from the insert using a Pasteur pipette. 
Make sure the slice is lying flat on the Transwell® membrane. 
 
v. Remove as much liquid as possible from the edges of the slice using a 
Pasteur pipette. 
 
vi. Place 1ml of medium (Medium-199 + 3% Penicillin-Streptomycin + 
0.001% ITS liquid media supplement) into the well in which the insert is 
placed.  
 
vii. Cover the 6 well plate with lid and transfer to an incubator. Slices 
should be incubated in humidified air at 37oC with 5%CO2. 
 
viii. Replace medium every 24 hours. Penicillin-Streptomycin concentration 
can be reduced to 1% after 24 hours. An additional wash in PBS + 3% 
Penicillin-Streptomycin can be carried out after 24 hours to prevent 
infections.  
 
B) Fixing & Staining 
 
i. Myocardial slices are fixed in 4% formaldehyde solution for 15 minutes 
at room temperature.  
 
PAUSEPOINT Fixed myocardial slices can be kept in PBS at 4oC for several 
months. 
 
ii. If permeabilization is required, permeabilize the fixed slice in 1% Triton 
X-100 for 1 hour at room temperature. 
 
iii. Block the slice using 10% FBS, 5% BSA and 10% horse serum in PBS 
solution (for several antibodies a weaker blocking (1%BSA) is 
sufficient). 
 
iv. Incubate slice in primary antibody in PBS at 4oC overnight. 
 
v. Wash the slice in PBS for 30 minutes. Repeat three times.  
 
vi. Incubate slice in secondary antibody in PBS for 3 hours at room 
temperature. 
 
vii. Wash the slice in PBS for 30 minutes. Repeat three times. 
 
PAUSEPOINT Stained myocardial slices can be kept at 4oC covered in aluminum 
foil for up to one week. Please be aware that secondary antibody fluorescence 
decreases with time and imaging samples directly after staining is recommended.  
 
TIMING 
 
Total time required: ~ 4 hours (excluding additional steps) 
- Reagent set up – 1 hour 
- Equipment set up – 1 hour 
- Excision of heart (step 1)– 5 minutes (if excision cannot take place in 
laboratory, additional  tissue transport time will be needed) 
- Preparation of left ventricular tissue block (steps 2-9) – 5-10 minutes 
- Slicing (steps 10-18)  – 0.5-1.5 hours (dependent on thickness of ventricle) 
- Additional steps: Culturing – 10-15 minutes to put 6 slices in culture, Fixing & 
Staining – 24 hours 
 
TROUBLESHOOTING 
 
For troubleshooting guidance see Table 3. 
 
Table 3: Troubleshooting table 
Step Problem Possible Reason Solution 
Equipment Setup -
Vibratome Calibration 
Z-axis error >1.0μm Blade is dirty Clean blade and 
blade holder with 70% 
ethanol. 
  Blade is damaged Replace blade 
  Blade not mounted 
correctly 
Remove blade and 
remount. Make sure 
the blade is 
positioned in the 
middle of the blade 
holder. 
Step 1A - Excision of 
small mammalian 
heart 
Heart is not beating 
following excision 
Excision took too 
long 
Discard heart. Make 
sure you have been 
adequately trained 
and have understood 
the methodology for 
excision. 
  Animal too 
deeply anaesthetized 
Closely observe the 
animal during 
anesthesia. Monitor 
level of 
consciousness (E.g.  
pedal reflex). 
Step 2A - Preparation 
of small mammalian 
left ventricular tissue 
block 
Heart is 
spontaneously 
contracting during 
dissection 
Heart is not 
sufficiently cooled 
Transfer the heart to 
the holding bath. 
Submerge in the cold 
(4oC) Tyrode's 
solution for 30 
seconds to 1 minute. 
Transfer heart to 
dissecting area and 
continue. Dissection 
needs to be as quick 
as possible. 
  Excitation-
Contraction 
uncoupler not added 
to slicing solution 
Ensure 2,3-
Butandione 
Monoxime has been 
added to slicing 
solution. 
Step 2B - Preparation 
of large mammalian 
left ventricular tissue 
block 
Whole heart not 
received 
Biopsy / part of the 
ventricle received 
Locate the epicardial 
surface of the tissue. 
Locate the flattest 
portion of the 
epicardium and 
dissect the tissue 
block from here. 
Step 9 - Mounting 
tissue block 
Tissue does not 
look flat on 
specimen holder 
Agarose not flat Ensure the agarose 
used to coat the 
specimen holder is 
flat. 
  Tissue mounted 
poorly 
Make sure the tissue 
is rolled onto the 
specimen holder to 
ensure even 
attachment over the 
entirety of the tissue 
  Tissue mounted 
endocardium-down 
The endocardium is 
significantly less flat 
than the epicardium. 
Discard tissue block 
and start again. 
Step 14 - Slicing Foam is appearing 
in slicing solution 
Slicing solution 
incorrectly made 
Tissue damage is 
occurring - check 
viability of slices prior 
to use 
  Tissue block poorly 
mounted 
Tissue damage is 
occurring - check 
viability of slices prior 
to use 
Step 15 - Handling 
myocardial slices 
Slice has not 
detached from the 
superior surface of 
the tissue block 
Fibrous tissue is 
present 
Use micro-scissors to 
free the slice by 
carefully cutting 
through any fibrous 
tissue. Make sure the 
blade has reached its 
final position and 
stopped vibrating 
before attempting 
this. 
  Vibratome hasn't cut 
through entirety of 
tissue 
Continue to slice until 
the slice detaches 
from the surface. 
Take care that the 
blade does not hit the 
back of the specimen 
holder. 
 
ANTICIPATED RESULTS:  
 
In this section we present typical data that we collected from healthy rat (small 
mammal) and failing human hearts (Human HF) (large mammal) myocardial slices. 
When we present N values this indicates: number of slices/number of hearts (E.g. 
10/5 = 10 slices derived from 5 hearts).  All data is presented as mean ± standard 
error. 
 
For structural and functional studies only aligned areas (myocardial fibers running 
parallel to each other) should be used. To visualize the aligned areas, place the 
myocardial slice on a petri dish and remove excess solution. Visualize the structure 
of a slice using a macroscope and determine the aligned area of the slice (Fig. 4). 
Using a scalpel/razor blade, trim the slice to isolate the aligned area and use for 
structural and functional studies. 
 
[Insert Fig. 4 here] 
 
Viability 
 
The viability of the surface of myocardial slices can be assessed using Live/Dead 
staining (Thermo Fisher Scientific). Live cells are stained green by calcein-AM and 
the nuclei of dead cells are stained red by ethidium homodimer-1. The surface of 
myocardial slices can be imaged with widefield microscopy (Fig. 5A) or confocal 
microscopy (Fig. 5B). The % area of living cells on the surface can be quantified 
using Image J (National Institute of Health, USA).  We found 59.4±6.4% of cells were 
alive on the surface of rat myocardial slices (N=11/6 – Fig. 5C) and 47.4±4.1% were 
alive on the surface of human HF slices (N=10/4 – Fig. 5D). 
 
[Insert Fig. 5 here] 
 
Imaging of the layer of cardiomyocytes directly below the slice surface revealed 
almost all of the cardiomyocytes were alive (Fig. 6A), indicating that tissue damage 
was limited to the slice surface. It was not possible to image the full thickness of the 
myocardial slice using confocal microscopy as the tissue is too optically dense. 
Calculations were used to estimate the viability of the myocardial slices. These 
revealed that the damaged cardiomyocytes on the myocardial slice surface account 
for ~3% of the total cardiomyocyte population within the slice, demonstrating 
preserved viability (See box below for full calculations). 
 
Estimation of the viability of adult rat ventricular myocardial slice 
 
The following calculations assume cardiomyocytes below the myocardial slice 
surface are 100% viable and a 7x7mm myocardial slice is used 
 
Myocardial slice volume: 14700000000μm3 
 
Estimation of average adult rat cardiomyocyte volume(41) 
 Percentage (%) Volume (μm3) 
Mononucleated cardiomyocytes 3.50 18006 
Binucleatued cardiomyocytes 96.50 25453 
 
∴ Average cardiomyocyte volume: 25192μm3 
 
 
Total cardiomyocytes in myocardial slice: 583519 
(Myocardial slice volume / Average cardiomyocyte volume) 
 
 
Estimation of  adult rat cardiomyocyte surface area exposed at the myocardial 
slice surfaces(42) 
 
 Length (μm) 
Average cardiomyocyte length 112 
Average cardiomyocyte width 25 
 
∴ Average exposed area of surface cardiomyocytes: 2800μm2 
(Average cardiomyocyte length x Average cardiomyocyte width) 
 
 
Exposed myocardial slice surface area: 106400000μm2 
(Both cut surfaces & edges) 
 
 
Total cardiomyocytes at the myocardial slice surface: 38000 
(Exposed myocardial slice surface area / exposed cardiomyocyte area) 
 
 
Number of dead cardiomyocytes at exposed myocardial slice surface: 15200 
(If we consider 40% of surface cardiomyocytes are killed during slicing) 
  
% dead cardiomyocytes within myocardial slice: 2.60% 
(Number of dead cardiomyocytes at surface / total number of cardiomyocytes) 
 
There are a number of critical steps that must be followed to produce slices of high 
viability. The method by which the tissue block is prepared is particularly important, 
especially for small mammals. The method described in this protocol ensures the left 
ventricle of small mammals is completely opened and consequently flattened. This is 
critical as the ventricles of small mammals have a pronounced curvature. Flattening 
of the ventricles ensures the long axes of the myocardial fibers lie in the same plane 
as the blade. When this is the case, the layers separate during slicing, resulting in 
minimal damage to cardiomyocytes within the slice. Due to the reduced curvature of 
the large mammalian ventricle, less dissection and flattening is required. However, 
with both small and large mammals, it is important to mount the tissue epicardium-
side down (epicardial surface in contact with agarose). The epicardium is 
significantly flatter than the endocardium, which is covered with papillary muscles, 
and this helps to correctly orientate the fibers. When the tissue is mounted 
endocardium-side down, it will have an increased curvature and more damage will 
occur at the edges of slices (Fig. 6B). When the tissue block is not flat myocardial 
fibers will be transected, reducing slice viability (Fig. 6C/D). It is not possible to 
prepare highly viable myocardial slices by simply sticking biopsies onto agarose 
when fiber direction is ambiguous. This also applies to embedding biopsies in 
agarose, which disregards fiber direction.  
 
[Insert Fig. 6 here] 
 
There are a number of additional factors that must also be considered to preserve 
viability. An important determinant is the way in which the cardiac tissue is 
explanted. Small mammalian hearts can be directly removed from the animal 
following sacrifice, while large mammalian hearts require cardioplegic arrest prior to 
explantation. The faster the heart is explanted and cooled, the higher the viability of 
myocardial slices. Therapeutic hypothermia is cardioprotective(43,44), reducing the 
tissue’s metabolic demand and the initiating protective signaling pathways(45). The 
time taken to slice is also crucial. Oxygen is unable to diffuse through the entirety of 
the ventricular wall and the tissue becomes increasingly ischaemic with time. This is 
minimized by tissue cooling, but any delays will impact on slice viability. Studies 
have shown that diffusion distances >200μm are generally poorly tolerated by 
tissues(33). 300μm slices have a maximum diffusion distance of 150μm from either 
surface and allow the rapid diffusion of substrates to their innermost cells(34). 
Thinner slices (100-250μm) can be prepared but they are more difficult to handle 
and, because of the lower number of cell layers, the proportion of damaged 
cardiomyocytes is increased. The use of an excitation-contraction uncoupler (2,3-
butanedione monoxime) prevents the cardiac tissue from contracting during slicing 
and its omission results in poor slice viability. The vibratome settings are also 
important and were optimized in our laboratory, as described in Camelliti et al(5). 
Other studies investigating optimal slicing solutions have been carried out and the 
solutions described in this protocol yielded the highest viability. 
 
Contractility 
 
A force transducer (Harvard Apparatus, USA) was used to assess the maximum 
contractility of myocardial slices. Rat and human HF slices were field stimulated at 
1Hz (Fig. 7A) and 0.5Hz (Fig. 7C) (10-30V), respectively. The maximum contractility 
was recorded by stretching slices in a step-wise manner. Custom PTFE-coated silver 
rings were attached to opposite ends of myocardial slices orthogonal to longitudinal 
fiber direction using Histoacryl surgical glue. Slices were stretched by ~5% and then 
left to contract for 2 minutes. This was repeated until isometric contraction was 
achieved and maximum contractility was recorded. Rat slices had a maximum 
contractility of 11.6±1.3mN/mm2 (N=10/10 – Fig. 7B). Human HF slices had a 
maximum contractility of 13.8±3.5mN/mm2 (N=9/9 – Fig. 7D).  
 
See Supplementary Video 8 to visualize a human heart failure and rat myocardial 
slices contracting on a force transducer. 
 
[Insert Fig. 7 here] 
 
Rat slices were paced at 1Hz, while human HF slices were paced at 0.5Hz. Rat 
slices are derived from healthy animals and can follow a field stimulus of >5Hz 
(resting heart rate around ~300bpm(46)). Human HF slices can be paced at >0.5Hz 
but at these rates the tissue cannot fully relax, reflecting the disease state of the 
tissue (end-stage HF, NYHA class IV). Myocardial slices can also be point stimulated 
(1V) (See “Supplementary Video 7”). 
 
 
Ca2+ Handling 
 
To assess Ca2+ handling, myocardial slices were loaded in Medium-199 (Sigma) with 
Fluo-4 AM (5.56μg/ml) (Thermo Fisher Scientific) and Pluronic F-127 (0.001%) 
(Thermo Fisher Scientific). A circular gauze and washer were placed over the slice 
(same as “Procedure – Step 17” / Supplementary Video 6) to prevent contraction 
during loading. Rat myocardial slices were loaded for 10 minutes at 37oC and then 
directly transferred to the optical mapping set up. Human HF slices were loaded for 
20 minutes and then left to de-esterify for a further 10 minutes in Tyrode’s solution 
with 30mM 2,3-Butandione Monoxime at 37oC.  2,3-Butandione Monoxime prevents 
movement artefact during calcium transient acquisition. Rat and human HF slices 
were field stimulated at 1Hz (Fig. 8A) and 0.5Hz (Fig. 8B) (30V), respectively. The 
average time to peak, time to 50% decay and 90% decay were analysed (Fig. 8C). 
Rat myocardial slices have a time to peak of 30.3±1.3ms, time to 50% decay of 
61.9±2.5ms and time to 90% decay of 153.3±8.5ms (N=24/6 – Fig. 8D). Human HF 
myocardial slices had a time to peak of 134.1±16.5ms, time to 50% decay of 
408.5±38.5ms and time to 90% decay 981.7±98.4ms (N=10/3 – Fig. 8E).  
 
[Insert Fig. 8 here] 
 
See Supplementary Video 9 to visualize Fluo-4 flashing on the surface of a rat 
myocardial slice. 
 
Conduction Velocity 
 
The conduction velocity of myocardial slices can be assessed using multielectrode 
arrays (Multichannel Systems), which allow non-invasive, synchronous, multifocal 
recording of extracellular field potential. Data were acquired with a 60 microelectrode 
plate, arranged in 8 x 8 matrix with a 700µm inter-electrode distance, providing a 
recording area of 4.9 x 4.9mm2. Representative conduction maps show the 
propagation of electrical activity in rat and human HF slices longitudinal (Fig. 9A & 
9D) and transverse (Fig. 9B & 9E) to myocardial fiber direction. Rat myocardial slices 
have a longitudinal conduction velocity of 60.9±7.7cm/s and a transverse conduction 
velocity of 21.9±2.1cm/s (both N=14/14 – Fig. 9C). Human HF myocardial slices 
have a longitudinal conduction velocity of 55.5±9.8cm/s and a transverse conduction 
velocity of 17.6±2.0cm/s (both N=11/4 – Fig. 9F). 
 
[Insert Fig. 9 here] 
 
Structural Studies 
 
The structure of myocardial slices can be investigated using various techniques. We 
have used immunohistochemistry and confocal microscopy. As myocardial slices 
can be stained and imaged either fresh or fixed and do not require sectioning, they 
are an ideal model for assessing cardiac structure. Sectioning requires tissue 
freezing, handling and processing and can result in sample damage. Due to tissue 
density and light scattering, imaging is limited to the surface of the preparation (2-3 
cell layers). A number of antibodies were used to visualize fundamental cardiac 
structures (see “Table 4” for further details). Caveolin 3 antibody was used to stain 
cardiomyocyte cell membranes and intercalated discs were stained with connexin-43 
antibody (Fig. 10A). The structure of the sarcomeric apparatus was assessed with α-
actinin staining (Fig. 10B). The microvasculature was stained with isolectin and the 
cardiac stromal cell population was stained with vimentin (Fig. 10C). More detailed 
assessment of myocardial slice ultrastructure can be carried out using scanning 
electron microscopy (Fig. 10D). To image the full thickness of the myocardial slice, 
optical clearing methods were used as described by Perbellini et. al(25). Second 
harmonic generation imaging was used to visualize collagen distribution within a 
human HF slice (Fig. 10E). The addition of antibody labelling for large blood vessels 
(vimentin) and high definition 3D reconstruction provided a precise map of the 
macrovascular network (Fig. 10F).  
 
Table 4: Antibodies 
 
Primary Antibodies 
Caveolin 3 Raised in 
mouse 
1 in 500 BD Biosciences 
Connexin-43 Raised in 
rabbit 
1 in 2000 Sigma 
α-Actinin Raised in 
mouse 
1 in 2000 Sigma 
Vimetin Raised in 
chicken 
1 in 3000 Thermo 
Scientific 
Isolectin B4 Biotin 
conjugated 
1 in 1000 Life 
Technologies 
 
Secondary Antibodies 
Alexa 488 Raised in 
donkey, Anti-
mouse 
1 in 2000 Life 
Technologies 
Alexa 546 Raised in 
donkey, Anti-
rabbit 
1 in 2000 Life 
Technologies 
Alexa 647 Raised in goat, 
Anti-chicken 
 
1 in 2000 Life 
Technologies 
 
Nuclear Staining 
Hoechst 33342  1 in 1000 Life 
Technologies 
 
 
[Insert Fig. 10 here] 
 
Conclusions 
 
Myocardial slices provide a unique platform that facilitate the study of myocardial 
structure and function at the cellular level in vitro. Myocardial slices have been 
produced for a number of years, but the protocols used have varied greatly 
(2,5,6,15). This protocol describes a robust and reproducible method for producing 
slices with high viability and addresses a number of critical steps that must be 
followed. The data presented represents a fraction of the studies that can be 
performed using myocardial slices. Data collected using myocardial slices has the 
advantage of being derived from native adult myocardium with preserved 
multicellularity and architecture. These aspects play important roles in myocardial 
function(28,29) and cannot be ignored. Due to their unique advantages and their 
ability to be chronically cultured, myocardial slices will be an important platform for 
future cardiovascular research. 
 
ACKNOWLEDGEMENTS: 
 
We would like to thank the British Heart Foundation for funding our work, particularly 
the BHF Centre for Regenerative Medicine award at Imperial College London and 
the MBBS PhD studentship to SW. We thank The Facility for Imaging by Light 
Microscopy (FILM) at Imperial College London, in particular Stephen M Rothery. 
Human samples were provided by the NIHR Cardiovascular Biomedical Research 
Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial 
College London. Canine samples were provided by GlaxoSmithKline. Porcine 
samples were provided by the Translational Biomedical Research Centre, University 
of Bristol. 
 
AUTHOR CONTRIBUTION STATEMENT: 
 
SW wrote the manuscript, collected data and contributed to the optimization of the 
protocol. MS collected data and contributed to the optimization of the protocol. IB 
contributed to the optimization of the protocol. RA provided porcine specimens. CT 
contributed to the optimization of the protocol. FP collected data and contributed to 
the optimization of the protocol. All authors proof read the manuscript.  
 
DISCLOSURES:  
The authors have nothing to disclose. 
 
FIGURE LEGENDS: 
 
Fig. 1  
Representative images of a rat myocardial slice. A) Original myocardial slice. 
Photograph taken directly after slicing. B) Aligned area. Photograph taken after the 
aligned area of the slice had been visualized under a macroscope and cut out using 
a scalpel (For further information, see “Fig. 4”).  
 
Fig. 2 
Apparatus required for the production of myocardial slices. A) Customized 6 well 
dish with holes drilled into the base of each well. B) Specimen holder covered with 
4% agarose. Both the base and the back of the holder should be completely 
covered.  C) Myocardial slice holding bath (without lid). Filled with cold slicing 
solution and bubbled with filtered 100% O2. Bath surrounded with ice to maintain a 
temperature of 4oC. D) Suggested dissection area set up. E) Right hand side – 
vibratome with vibratome bath in place. Outer section of bath is filled with ice and 
inner section is filled with cold slicing solution, bubbled with filtered 100% O2. Left 
hand side – myocardial slice holding bath covered with lid. Holding path placed on 
ice. 
 
Fig. 3  
Preparation of small mammalian (rat) left ventricular tissue block. These images 
show dissection with a dry heart to aid visualization of the method. However, always 
dissect tissue in a petri dish with the tissue submerged in cold slicing solution. For 
further details, please consult step 2A.  A) Using a surgical scalpel/razor blade, 
dissect off the lungs and other tissues. B) Visualize the atria and make an incision 
slightly inferiorly, through the base of the ventricle. C) Visualize the right ventricle, 
which has a thinner wall and is more cresentic in shape. Hold the free wall of the 
right ventricle with tweezers. D) Using micro-scissors, cut along the right ventricular-
septal junction on one side. Cut towards apex. E) Lift the cut border of the right 
ventricle away from the heart. F) Cut along the other ventricular-septal junction to 
remove the right ventricle. G) Place one edge of the micro-scissors inside the left 
ventricle and cut along the septum towards the apex. H) The ventricle should now 
open. I) Make small incisions along the borders of the tissue block to allow the 
ventricle to fully flatten. Fibrotic tissue and large papillary muscles will also need to 
be cut. J) Turn the tissue block over so the epicardium is facing upwards. Visualize 
the edges of the septum at the lateral edges of the tissue block. Remove with 
surgical scalpel/razor blade. K/L) Flat left ventricular tissue block. Tissue block is 
20x12mm in size.  
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
   
Fig. 4 
Rat myocardial slice on a 1mm grid visualized using a macroscope. Aligned area, 
where myocardial fibers are parallel, is highlighted in green. This area is appropriate 
for structural and functional studies. Non-aligned areas are highlighted in red.   
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
Fig. 5  
Myocardial slice viability. Viability was assessed using a Live/Dead staining. Live 
cells are stained green (Calcein-AM), the nuclei of dead cells are stained red 
(Ethidium homodimer-1). A) Representative image of Live/Dead staining of a rat 
myocardial slice imaged using widefield microscopy. Scale bar = 1000μm B) 
Representative image of Live/Dead staining of a human HF myocardial slice imaged 
using confocal microscopy. Scale bar = 300μm C) 59.4±6.4% of the surface of rat 
myocardial slices was alive (N=11/6). D) 47.4±4.1% of the surface of human HF 
myocardial slices was alive (N=10/4).  
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
Data is presented as mean ± standard error 
N = number of slices/number of hearts 
 
Fig. 6 
Understanding the viability of myocardial slices. A) ~50-60% of cardiomyocytes on 
the surface of myocardial slices were alive. Living cardiomyocytes were stained 
green (Calcein-AM), while the nuclei of dead cardiomyocytes were stained red 
(Ethidium Homodimer-1). Images were acquired using confocal microscopy. Deep 
imaging of the layers of cardiomyocytes below the surface revealed that almost 
100% of cardiomyocytes below the surface were alive. The representative animation 
shows live cells in green and dead cells in red. Animation of slice surface shows 
~50% of cells alive. Animation of layer of cardiomyocytes just below the slice surface 
shows almost all cardiomyocytes are alive. B) The tissue block should never be 
mounted endocardium-down. When this is the case, the tissue block has an 
increased curvature which results in large portions of tissue being damaged. 
Damage usually occurs on the lateral portions of slices. C/D) When the tissue block 
is not flat, myocardial fibers can be transected. Slices were stained with α-actinin 
(see ‘Table 4’; further information on fixing and staining myocardial slices can be 
found in “Procedure – Additional Steps – Fixing & Staining”) and imaged using 
confocal microscopy. The images show areas of undamaged cardiomyocytes 
alongside areas where cardiomyocytes have been transected. Cardiomyocytes lying 
in the same plane as the blade are undamaged, while those lying perpendicular to 
the blade are transected.  
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
Fig. 7 
Contractility of rat and human HF myocardial slices. A) Representative contractility 
traces from rat myocardial slice field stimulated at 1Hz. B) Maximum contractility of 
rat myocardial slices was 11.6±1.3mN/mm2 (N=10/10). C) Representative 
contractility traces from human HF myocardial slices field stimulated at 0.5Hz. D) 
Maximum contractility of human HF myocardial slices was 13.8±3.5mN/mm2 (N=9/9).  
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
Data is presented as mean ± standard error 
N = number of slices/number of hearts 
 
Fig. 8  
Ca2+ handling of rat and human HF myocardial slices was assessed by loading slices 
with Fluo-4 AM and optical mapping. A) Representative Ca2+ transient from a rat 
myocardial slice field stimulated at 1Hz. B) Representative Ca2+ transient from a 
human HF myocardial slice field stimulated at 0.5Hz. C) Visual description of the 
aspects of Ca2+ handling kinetics assessed. D) Ca2+ handling kinetics of rat 
myocardial slices field stimulated at 1Hz. E) Ca2+ handling kinetics of human HF 
myocardial slices field stimulated at 0.5Hz. 
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
Data is presented as mean ± standard error 
N = number of slices/number of hearts 
 
Fig. 9 
Conduction velocity of rat and human HF myocardial slices. A&B) Representative 
conduction maps from rat myocardial slices, with electrical propagation longitudinal 
(A) and transverse (B) to myocardial fiber direction. C) Rat myocardial slices have a 
longitudinal conduction velocity of 60.9±7.7cm/s and a transverse conduction 
velocity of 21.9±2.1cm/s (N=14/14). D&E) Representative conduction maps from 
human HF myocardial slices, with electrical propagation longitudinal (D) and 
transverse (E) to myocardial fiber orientation. F) Human HF myocardial slices have a 
longitudinal conduction velocity of 55.5±9.8cm/s and a transverse conduction 
velocity of 17.6±2.0cm/s (N=11/4).  
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
Data is presented as mean ± standard error 
N = number of slices/number of hearts 
 
Fig. 10  
Cardiac structure studied using myocardial slices. A-C) Immunohistochemical 
staining and confocal microscopy of rat myocardial slices. A) The cell membranes of 
cardiomyocytes have been stained with caveolin 3 antibody, the intercalated disc is 
stained with connexin-43 antibody & nuclei are labelled with Hoechst 33342. B) The 
sarcomeric apparatus is stained with α-actinin antibody and nuclei are labelled with 
Hoechst 33342. C) Microvasculature is stained with isolectin antibody, the cell 
membranes of cardiomyocytes are stained with caveolin 3 antibody, fibroblasts are 
stained with vimentin antibody and nuclei are labelled with Hoechst 33342. D) 
Scanning electron microscopy of human HF myocardial slice. Transverse section. 
Grey structures are cardiomyocytes and the smaller, darker substructures are 
mitochondria. E/F) Optical clearing was used to image the full thickness of 
myocardial slices (300μm)(25). Second harmonic generation imaging was used to 
visualize collagen distribution within a human HF myocardial slice (E). The 
macrovascular network was imaged using this method and the addition of a vimentin 
antibody (F).  Further information on the antibodies used can be found in “Table 4”. 
The fixing and staining protocol used is described in “Procedure – Additional Steps – 
Fixing & Staining”.  
 
Imperial College London provided permission for the use of the animals in this study. 
All procedures were performed under license by the UK Home Office, in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986. Animals were 
killed following guidelines established by the European Directive on the protection of 
animals used for scientific purposes (2010/63/EU). 
 
SUPPLEMENTARY VIDEO LEGENDS 
 
Supplementary Video 1 
Preparation of left ventricular tissue block from small mammalian heart (Rat) – Part 
1. Video depicts steps 2A i-vii. 
 
The preparation of the tissue block in this video has been carried out slowly to aid 
the visualization of the technique. However, tissue block preparation should be 
carried out as quickly as possible. Tissue should be kept cool throughout. If tissue 
contracts during block preparation, transfer to holding bath and allow to cool for 30 
seconds. 
 
Supplementary Video 2 
Preparation of left ventricular tissue block from small mammalian heart (Rat) – Part 
2. Video depicts steps 2A viii-x. 
 
The preparation of the tissue block in this video has been carried out slowly to aid 
the visualization of the technique. However, tissue block preparation should be 
carried out as quickly as possible. Tissue should be kept cool throughout. If tissue 
contracts during block preparation, transfer to holding bath and allow to cool for 30 
seconds. 
 
Supplementary Video 3 
Preparation of left ventricular tissue block from small mammalian heart (Rat) – Part 
3. Video depicts step 2A xi. 
 
The preparation of the tissue block in this video has been carried out slowly to aid 
the visualization of the technique. However, tissue block preparation should be 
carried out as quickly as possible. Tissue should be kept cool throughout. If tissue 
contracts during block preparation, transfer to holding bath and allow to cool for 30 
seconds. 
 
Supplementary Video 4 
Mounting of left ventricular tissue block on agarose-coated specimen holder. Video 
depicts how to handle, dry and mount tissue block correctly. 
 
Supplementary Video 5 
Slicing of left ventricular tissue block. Video depicts bringing blade to “starting 
position” and various stages of slicing. 
 
Supplementary Video 6 
Handling & storage of myocardial slices. Video depicts how to move a myocardial 
slice from vibratome bath to holding bath. Video also shows how myocardial slices 
should be kept in holding bath. 
 
Supplementary Video 7 
Culturing myocardial slices using air-liquid interface method. Video depicts how to 
culture myocardial slices on an air-liquid interface using Transwell® membranes as 
described by Brandenburger et al(2). 
 
Supplementary Video 8 
Myocardial slice contraction. Video depicts a human HF myocardial slice contracting 
(field stimulation, 0.5Hz, 30V) and a rat myocardial slice contracting (point 
stimulation, 1Hz, 10V). 
 
Supplementary Video 9 
Ca2+ handling of myocardial slices. Rat myocardial slice was loaded with Fluo-4 AM 
(as described in ‘Anticipated Results – Ca2+ handling’). Myocardial slice was field 
stimulated at 1Hz, 10V. Cardiomyocytes at the slice surface flash with each calcium 
transient. 
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